Performance of the new Roche Cobas AmpliPrep-Cobas TaqMan version 2.0 human immunodeficiency virus type 1 assay.
about
HIV and hepatitis C virus infection in the United States: whom and how to testAbility of two commercially available assays (Abbott RealTime HIV-1 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Version 2.0) to quantify low HIV-1 RNA Levels (<1,000 copies/milliliter): comparison with clinical samples and NIBSC working reagent forViral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe.Comparative evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 version 2 test using the TaqMan 48 analyzer and the Abbott RealTime HIV-1 assayPotential influence of more-sensitive HIV-1 load detection by the new Roche Cobas AmpliPrep/Cobas TaqMan version 2.0 assay on clinical management of HIV-positive pregnant womenAbbott RealTime HIV-1 m2000rt viral load testing: manual extraction versus the automated m2000sp extraction.Detection of Acute HIV-1 Infection by RT-LAMP.Current practices in laboratory monitoring of HIV infection.Early diagnosis of in utero and intrapartum HIV infection in infants prior to 6 weeks of age.Use of a prequalification panel for rapid scale-up of high-throughput HIV viral load testing.Concordance of HIV-1 RNA Values by Amplicor and TaqMan 2.0 in Patients With Confirmed Suppression in Clinical TrialsCurrent challenges to viral load testing in the context of emerging genetic diversity of HIV-1.Sensitivity and specificity of dried blood spots for HIV-1 viral load quantification: A laboratory assessment of 3 commercial assaysHIV-1 load comparison using four commercial real-time assaysComparison of the COBAS/Ampliprep Taqman and Amplicor HIV-1 monitor tests in Lagos, Nigeria.Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets.
P2860
Q26996736-1B862BA2-46C3-41B6-85CF-9C16AD3DE484Q33703537-392481DF-2CA1-44B1-9CA3-D91B1C1512B9Q33788085-C6D35ED4-9D5C-4637-BC4F-676DBA6883E7Q34487739-9419995E-C41C-42F2-B8FC-F454E020F563Q34489603-C7651CFA-5005-4559-9B0F-F71700869BB6Q35189996-298EA463-CB1D-4723-AAC2-C27259105BABQ35628887-1CEDE466-8F72-4622-A027-A04394828CE5Q35770853-B4D022AC-1CBE-4623-BADB-E0944BC37B9AQ36118718-E3DFED67-0415-4EC8-8805-DDA420286AC0Q36414140-87C65336-0130-4F31-ADF3-5DDDECDE89AEQ37221125-73517637-CDE3-44F7-9E4F-FBDE86573CC5Q38088726-E91EE866-E3F9-4977-B19B-DE9616131C1AQ39336961-628FCDA0-2E87-4034-A544-B5B3CC862A3CQ42113208-D6DA5904-9D99-43A0-AE1F-B1260F01C6D2Q45045900-2F5AC016-0280-4231-B198-E1F1ED890DBDQ45364475-0982768A-D4E9-418B-82CB-50804D66DF58
P2860
Performance of the new Roche Cobas AmpliPrep-Cobas TaqMan version 2.0 human immunodeficiency virus type 1 assay.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Performance of the new Roche C ...... deficiency virus type 1 assay.
@en
Performance of the new Roche C ...... deficiency virus type 1 assay.
@nl
type
label
Performance of the new Roche C ...... deficiency virus type 1 assay.
@en
Performance of the new Roche C ...... deficiency virus type 1 assay.
@nl
prefLabel
Performance of the new Roche C ...... deficiency virus type 1 assay.
@en
Performance of the new Roche C ...... deficiency virus type 1 assay.
@nl
P2860
P356
P1476
Performance of the new Roche C ...... odeficiency virus type 1 assay
@en
P2093
Lesley Scott
Wendy Stevens
P2860
P304
P356
10.1128/JCM.00727-09
P407
P577
2009-08-05T00:00:00Z